Finnish biopharmaceutical company Aplagon has secured a financing of €7m ($7.24m) to advance its heparin proteoglycan mimetic ...

Aplagon, a clinical stage biopharmaceutical company developing a first-in-class therapeutic for thrombo-inflammatory diseases, known as APAC, a heparin proteoglycan mimetic with antiplatelet and ...

It would be impossible to overstate the late David Lynch‘s impact on The A.V. Club, past and present. To pay tribute, we’re touching up some archival posts and lining up additional features ...

Fear is contagious, and it can evolve into something worse. So too can the false certainty that the things we fear can be outplanned or outwitted. An anxious film initially written during the ...

However, in theory any blood flow dysregulation to area postrema could be a cause of APS as this area mainly functions in osmoregulation. We present a case of APS secondary to a dural arteriovenous ...

Intracranial dural arteriovenous fistula (AVF) is a rare vascular condition characterized by an abnormal arterio‐venous shunt within the dura, often involving sinus or cortical venous drainage. AVFs ...

Among the TAE patients, four kinds of vascular injury were observed, namely, 18 cases of pseudoaneurysm (PA), 12 cases of arteriocaliceal fistula (ACF), 7 cases of arteriovenous fistula (AVF), and 1 ...